2002
DOI: 10.1111/j.1524-6175.2002.02045.x
|View full text |Cite
|
Sign up to set email alerts
|

Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Abstract: Context. Blood pressure control (<140/90 mm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

6
106
0
5

Year Published

2003
2003
2015
2015

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 815 publications
(117 citation statements)
references
References 21 publications
6
106
0
5
Order By: Relevance
“…Similarly, Medicare beneficiaries were more often aware of their hypertension and receiving treatment, but had relatively high rates of uncontrolled hypertension. Besides the confounding effect of age, this may be due in part to treatment‐resistant hypertension being more prevalent among older patients 24, 25. In addition, despite being insured and receiving relatively low‐cost medications, Medicare patients may still face a financial barrier to adherence and, hence control, when they enter the Medicare prescription drug plan coverage gap, also known as the “donut hole.”26, 27 We also found that younger individuals and those with few or no visits for health care in the last year were often unaware of their hypertension, and when aware they were less likely to receive treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, Medicare beneficiaries were more often aware of their hypertension and receiving treatment, but had relatively high rates of uncontrolled hypertension. Besides the confounding effect of age, this may be due in part to treatment‐resistant hypertension being more prevalent among older patients 24, 25. In addition, despite being insured and receiving relatively low‐cost medications, Medicare patients may still face a financial barrier to adherence and, hence control, when they enter the Medicare prescription drug plan coverage gap, also known as the “donut hole.”26, 27 We also found that younger individuals and those with few or no visits for health care in the last year were often unaware of their hypertension, and when aware they were less likely to receive treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, in the most recent hypertension trials, such as the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT [5]), the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial (6) and the AngloScandinavian Cardiac Outcomes Trial (ASCOT [7]), as well as in older hypertension trials, a large proportion of patients required two or even three antihypertensive medications to achieve target BPs. For example, at the conclusion of the ALLHAT, in controlled patients, approximately 30% of patients were on dual therapy and 20% of patients were on triple therapy (8). Accordingly, one can anticipate needing to use multiple antihypertensive medications in patients with Achieving blood pressure targets in hypertension can be challenging.…”
mentioning
confidence: 99%
“…[1][2][3] An important part of this problem is current prescribing practices. Unfortunately, most patients require Ն2 medications to achieve optimal control, 4 and these multidrug regimens are associated with lower adherence. 5,6 This has been suggested to be the most important contribution to inadequate blood pressure control.…”
mentioning
confidence: 99%